KineMed Revenue and Competitors
Estimated Revenue & Valuation
- KineMed's estimated annual revenue is currently $2.8M per year.
- KineMed's estimated revenue per employee is $155,000
Employee Data
- KineMed has 18 Employees.
- KineMed grew their employee count by -10% last year.
KineMed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | president and ceo | Reveal Email/Phone |
2 | CEO & Chairman | Reveal Email/Phone |
3 | Co-Founder, Chairman Scientific Advisory Board | Reveal Email/Phone |
KineMed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is KineMed?
KineMed, Inc. (www.kinemed.com), a privately held biotechnology company based in Emeryville, CA, is a leader in translational and personalized medicine. KineMed uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases. KineMed is developing a focused, high-quality pipeline of its own in-licensed compounds.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.8M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.6M | 18 | -14% | N/A |
#2 | $3.1M | 20 | -23% | N/A |
#3 | $3.1M | 20 | -9% | N/A |
#4 | $3.3M | 21 | -5% | N/A |
#5 | $3.7M | 21 | 62% | N/A |
